BackAimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 Overview
Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 P/E Ratio

Latest P/E ratio for Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028: 72.79 — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

72.79

P/E Ratio

72.79

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 (AFJKR) FAQ

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028's p/e ratio stands at 72.79. That is above the sector sector average of 47.3. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 sits higher the its sector benchmark (47.3) with a P/E ratio of 72.79. That is roughly 53.9% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

Whether 72.79 is attractive depends on Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.

The history chart shows how Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028's P/E ratio evolved across reporting periods, while the comparison chart places AFJKR next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.